Trial NCT03468075

View at ClinicalTrials.gov 
Org. Study IDs: 201802800 (Phase II)

Last trial update was posted on 2020-12-10

MeSH Interventions

Ascorbic Acid Gemcitabine

MeSH Conditions

Osteosarcoma Sarcoma

Other Conditions

Bone Sarcoma Metastatic Bone Tumor Soft Tissue Sarcoma Unresectable Soft Tissue Sarcoma

Stopping Reasons

Stopping rules met

Limitations And Caveats

Study terminated early. Ten patients were enrolled in the first stage, and per protocol the study was terminated following interim analysis when 1 or fewer participants had a tumor response.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID